Loading...

Corcept Therapeutics Incorporated

CORT•NASDAQ
Healthcare
Biotechnology
$46.06
$0.98(2.17%)
U.S. Market opens in 49h 27m

Corcept Therapeutics Incorporated (CORT) Stock Overview

Explore Corcept Therapeutics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.9B
P/E Ratio48.46
EPS (TTM)$0.82
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$55.48
3 Months$48.00
1 Year Target$85.68

CORT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Corcept Therapeutics Incorporated (CORT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $85.68.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 48.46 and a market capitalization of 4.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.17%
5-Day Change
3.41%
1-Month Change
36.19%
3-Month Change
4.73%
6-Month Change
-36.49%
Year-to-Date (YTD) Change
32.36%
1-Year Change
-35.84%
3-Year Change
104.71%
5-Year Change
89.47%
All-Time (Max) Change
276.61%

Contact Information

https://www.corcept.com
650 327 3270
149 Commonwealth Drive, Menlo Park, CA, 94025

Company Facts

500 Employees
IPO DateApr 14, 2004
CountryUS
Actively Trading

Frequently Asked Questions